The FDA has reportedly refused to review Moderna's application for an mRNA flu vaccine, although there is some uncertainty about the decision, with one outlet suggesting the FDA had reversed course and would review the application. Most outlets agree that the FDA will not review the application. The reason for the FDA's decision is not specified in the available information.